← Back to Clinical Trials
Recruiting NCT05294068

NCT05294068 Barriers to Physical Activity in Patients With Cognitive, Neuromotor or Sensory Impairments During Aging

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05294068
Status Recruiting
Phase
Sponsor Institut de Sante Parasport Connecte Synergies
Condition Disability or Chronic Disease Leading to Disablement
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2022-04-01
Primary Completion 2032-02-01

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
standard of care for patients with cognitive impairmentsstandard of care for patients with neuromotor impairmentsstandard of care for patients with sensory impairments

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2022-04-01 with a primary completion date of 2032-02-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

People with disabilities are less physically active than the general population. Their barriers to physical activity are multiple and include intrapersonal, organizational, societal and interpersonal reasons. Nevertheless, at present, the evolution of their barriers to physical activity and the short- and long-term impact of medical and medico-social treatments to limit them are unknown. The aim of this study is to describe barriers to physical activity, or disability-related underperformance factors in competitive sports, in patients with cognitive, neuromotor or sensory impairments during aging.

Eligibility Criteria

Inclusion Criteria: * Patients \>= 6 years old ; * Consulting to the Parasport Health Unit of the Physical Medicine and Rehabilitation Department of our university hospital ; * Having a neuromotor, cognitive or sensory impairment ; * No opposition to be enrolled in the study from the patient, or from a legally authorized close relative if the patient's state of health does not allow it, or from each of the holders of parental authority if a minor ; * Affiliation to a social security scheme. Exclusion Criteria: * Under court protection.

Contact & Investigator

Central Contact

François Genêt, MD-PhD

✉ francois.genet@aphp.fr

📞 +33 1 47 10 70 82

Principal Investigator

François Genêt, MD-PhD

PRINCIPAL INVESTIGATOR

Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France

Frequently Asked Questions

Who can join the NCT05294068 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, studying Disability or Chronic Disease Leading to Disablement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05294068 currently recruiting?

Yes, NCT05294068 is actively recruiting participants. Contact the research team at francois.genet@aphp.fr for enrollment information.

Where is the NCT05294068 trial being conducted?

This trial is being conducted at Garches, France.

Who is sponsoring the NCT05294068 clinical trial?

NCT05294068 is sponsored by Institut de Sante Parasport Connecte Synergies. The principal investigator is François Genêt, MD-PhD at Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology